stockrow
Saturday 7 November 2026
Export LBRX’s income statement to Excel — free account
LB Pharmaceuticals Inc
LBRX Healthcare Biotechnology
- EPS
- +87.4%
- Free cash flow
- −579.0%
Quarter to June 2026, against a year earlier
42.01
3.92
+10.29%
Follow LBRX
Alert me
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Dec '24 | Dec '25 | |
|---|---|---|
Cash and Short Term Investments |
28.00 | 295.21 |
Total current assets |
28.88 | 308.43 |
Property, Plant, Equpment (Net) |
1.86 | 1.58 |
Long-term assets (Other) |
0.50 | 0.77 |
Total non-current assets |
4.66 | 4.50 |
Total Assets |
33.53 | 312.93 |
Accounts Payable |
2.32 | 2.13 |
Accrued Expenses |
5.30 | 4.59 |
Total current liabilities |
8.11 | 7.44 |
Non-current Liabilities (Other) |
2.50 | 1.34 |
Total non-current liabilities |
5.72 | 4.18 |
Total liabilities |
13.83 | 11.62 |
Additional Paid In Capital |
9.66 | 430.67 |
Preferred Stock (Total) |
114.26 | — |
Common Stock (Net) |
0.00 | 0.00 |
Retained Earnings |
(104.32) | (129.53) |
Common Equity (Total) |
(94.55) | 301.31 |
Shareholders Equity (Total) |
19.71 | 301.31 |
Shareholders Equity and Liabilities (Total) |
33.53 | 312.93 |
Shares (Common) |
0.25 | 25.30 |
Shares (Preferred) |
78.07 | — |
Shareholders Equity (Tangible) |
19.71 | 301.31 |
Net Debt |
(28.00) | (295.21) |
In millions of $ except per-share values · columns are period end dates · fundamentals updated 25 Oct 2026